Zurich Cantonal Bank
AUPH icon

Zurich Cantonal Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Zurich Cantonal Bank’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,681
Closed -$745K – 2652
2025
Q4 		$745K Buy
+46,681
New +$662K ﹤0.01% 1530

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Zurich Cantonal Bank's AUPH Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2026: 54,430 shares worth $807K. The stake represents ﹤0.01% of the portfolio and ranks #1560 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in AUPH as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in AUPH in Q2 2018 and has held it in 31 quarters since. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Zurich Cantonal Bank held 54,430 shares of Aurinia Pharmaceuticals worth $807K as of Q1 2026.
  • Aurinia Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #1560 holding.
  • Zurich Cantonal Bank first reported a position in Aurinia Pharmaceuticals in Q2 2018 and has held it in 31 quarters since.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.